| Application no. and date | 09723808.3 (espacenet) (Federated) (European Patent Register), 20090323 | | Patent/reg. no. and date | DK/EP 2268310, 20160720 | | Publication date | 20110105 | | Priority no. and date | EP 08005554, 20080325, EP 08007172, 20080411 | | EP pub. no. and date |
EP 2268310 20110105 | | Effective date | | | Applicant/owner | Roche Glycart AG, Wagistrasse 18
8952 Schlieren-Zuerich, CH | | Applicant ref. no. | P59291dk01 | | Inventor | HERTING, Frank, An der Freiheit 29a
82377 Penzberg, DE,
DUMONTET, Charles, 11 Chemin du Laquay
F-69200 Venissieux, FR,
FRIESS, Thomas, St. Martin Strasse 8a
86911 Diessen-Dettenhofen, DE,
UMANA, Pablo, Felsenrainstrasse 28
CH-8832 Wollerau, CH,
KLEIN, Christian, Chapfstrasse 26B
8906 Bonstetten, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Title | ANVENDELSE AF ET TYPE II ANTI-CD20-ANTISTOF MED FORHØJET ANTISTOF-AFHÆNGIG CELLULÆR CYTOTOXICITET (ADCC) I KOMBINATION MED CYCLOPHOSPHAMID, VINCRISTIN OG DOXORUBICIN TIL BEHANDLING AF NON-HODGKIN'S LYMFOM | | Int. application no. | EP2009002111 | | Int. publication no. | WO2009118142 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
